DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Specialty Active Pharmaceutical Ingredients (API) Market: Global Industry Analysis and Opportunity Assessment, ...

ANÁPOLIS, BR / ACCESS Newswire / December 28, 2025 / Brook S/A, a Brazilian pharmaceutical company led by entrepreneur Wesley ...

Jan 31 (Reuters) - Teva Pharmaceutical Industries TEVA.TA will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs maker said on ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...

The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...

Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...

Eight months after convincing five companies to pay fines to settle antitrust claims, the European Commission has zeroed in on another firm, active pharmaceutical ingredients (API) manufacturer Alchem ...